API Holdings, the parent company of online pharmacy PharmEasy, announced last week that it would pick up a 66.1 per cent stake in diagnostics firm Thyrocare for Rs 4,546 crore. It is the first unicorn to acquire a listed company.
- Persistent Systems Shares Surge 5% on Launching ContractAssIst
- Adani Green Energy Shares Soar 7% as Arm Comisiones 57 MW Wind Power Component
- IRFC Shares Rally 3% on Emerging L1 for Banhardih Coal Block Financing
- Minda Corporation Shares Rally 5% on Plans to Acquire Stake in Flash Electronics
- Stocks Under F&O Ban: Hindustan Copper, RBL Bank, and Others
One of the most extensive consolidations in the domestic health care space, the deal was struck in record time at the Mumbai residence of A Velumani, founder of Thyrocare. The deal is also a milestone for five friends from the Mumbai suburb of Ghatkopar, who called themselves the Ghatkopar Gujju gang and set up PharmEasy in 2015.
